Comparison of elderly and young onset rheumatoid arthritis

Comparison of elderly and young onset rheumatoid arthritis

Objective: To describe demographic, clinical, paraclinical and therapeutic characteristics of elderly onset (EORA) compared to young-onset (YORA) rheumatoid arthritis. Patients and Methods: We studied 50 EORA and 100 YORA. Socio-demographic characteristics, clinical and paraclinical data of the dis...

Full description

Bibliographic Details
Main Authors:	N. Jaouad, B. Amine, I. Elbinoune, S. Rostom, R. Bahiri
Format:	Article
Language:	English
Published:	Verduci Editore 2022-12-01
Series:	Beyond Rheumatology
Subjects:	rheumatoid arthritis elderly onset young-onset disease activity life quality comorbidities disease modifying antirheumatic drugs
Online Access:	https://www.beyond-rheumatology.org/wp-content/uploads/sites/10/2022/12/e445.pdf

Similar Items

Comparison of the drug retention and reasons for discontinuation of tumor necrosis factor inhibitors and interleukin-6 inhibitors in Japanese patients with elderly-onset rheumatoid arthritis—the ANSWER cohort study
by: Sadao Jinno, et al.
Published: (2021-04-01)

Elderly-Onset Rheumatoid Arthritis: Characteristics and Treatment Options
by: Slavica Pavlov-Dolijanovic, et al.
Published: (2023-10-01)

Inflammatory profile of incident cases of late-onset compared with young-onset rheumatoid arthritis: A nested cohort study
by: Natalia Mena-Vázquez, et al.
Published: (2022-11-01)

Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: Differences in pathogenesis
by: Jinzhi Wu, et al.
Published: (2023-01-01)

Effect of immunomodulating treatment (usage of DMARDs) in rheumatoid arthritis on depression
by: Magdalena Kozyra, et al.
Published: (2020-08-01)

Risk of New-Onset Diabetes Mellitus Associated with Antirheumatic Drugs in Patients with Rheumatoid Arthritis: A Nationwide Population Study
by: So Hye Nam, et al.
Published: (2022-04-01)

Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
by: Xia Y, et al.
Published: (2016-05-01)

First-year drug therapy of new-onset rheumatoid and undifferentiated arthritis: a nationwide register-based study
by: Paula Muilu, et al.
Published: (2020-07-01)

MODERN VIEWS ON PATHOGENETIC THERAPY OF RHEUMATOID ARTHRITIS
by: D. G. Rekalov, et al.
Published: (2013-12-01)

Association of Hydroxychloroquine Use with a Dose-Dependent Decrease in Mortality Risk in Patients with Elderly-Onset Rheumatoid Arthritis
by: Ching-Tsai Lin, et al.
Published: (2023-05-01)

Prospects for rheumatoid arthritis pharmacotherapy: New opportunities and recommendations
by: E L Nasonov
Published: (2016-12-01)

Conventional disease-modifying agents in rheumatoid arthritis – a review of their current use and role in treatment algorithms
by: Ivan Padjen, et al.
Published: (2020-12-01)

Early rheumatoid arthritis therapy: comparative characteristic of delagil, sulphasalazine and methotrexate
by: T S Salnikova, et al.
Published: (2003-08-01)

CD8<sup>+</sup> Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis
by: Ryu Watanabe, et al.
Published: (2023-03-01)

Comparison between Young and Elderly Onset of Rheumatoid Arthritis in a Romanian Cohort
by: Anca BOBIRCA, et al.
Published: (2022-03-01)

Polymyalgia Rheumatica and Seronegative Elderly-Onset Rheumatoid Arthritis: Two Different Diseases with Many Similarities
by: Ciro Manzo, et al.
Published: (2019-09-01)

Rheumatoid arthritis – medication dosage in chronic kidney disease
by: Kinga Maria Tyczyńska, et al.
Published: (2024-01-01)

Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis
by: Bernard Combe, et al.
Published: (2022-10-01)

Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study
by: Seogsong Jeong, et al.
Published: (2022-07-01)

Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response – results from the multicenter observational ACT-POL study
by: Marcin Stajszczyk, et al.
Published: (2022-05-01)

Childhood-onset rheumatoid arthritis at a tertiary hospital in Senegal, West Africa
by: Mounib M. Sabounji, et al.
Published: (2023-09-01)

STRATEGY FOR DOSE REDUCTION AND DISCONTINUATION OF BIOLOGICAL AGENTS IN RHEUMATOID ARTHRITIS REMISSION
by: M. A. Kotovskaya, et al.
Published: (2018-03-01)

Subjective sleep disturbances at the time of diagnosis in patients with polymyalgia rheumatica and in patients with seronegative elderly-onset rheumatoid arthritis. A pilot study
by: Ciro Manzo, et al.
Published: (2020-08-01)

iTRAQ and PRM-Based Proteomic Analysis Provides New Insights into Mechanisms of Response to Triple Therapy in Patients with Rheumatoid Arthritis
by: Chen J, et al.
Published: (2021-12-01)

A Comparison of Demographics, Disease Activity, Disability, and Treatment Among Rheumatoid Arthritis Patients with and without Osteoporosis
by: Abdulkhaliq A, et al.
Published: (2021-09-01)

Patients With Rheumatoid Arthritis With an Inadequate Response to Disease‐Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome
by: Chung‐Yuan Hsu, et al.
Published: (2021-04-01)

The clinical and pathogenetic value of Foxp3+ T regulatory cells in rheumatoid arthritis
by: A. S. Avdeeva, et al.
Published: (2016-10-01)

The clinical utility of musculoskeletal ultrasound for disease activity evaluation and therapeutic response prediction in rheumatoid arthritis patients: A narrative review
by: Chia-Ching Chen, et al.
Published: (2023-01-01)

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment
by: van Heuckelum M, et al.
Published: (2019-07-01)

Nitric Oxide Synthases in Rheumatoid Arthritis
by: Jia-Bao Huang, et al.
Published: (2023-05-01)

PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS
by: V. N. Amirdzhanova, et al.
Published: (2014-09-01)

CARDIOVASCULAR DISEASES IN RHEUMATOID ARTHRITIS: LATEST DATA
by: T. V. Popkova, et al.
Published: (2016-07-01)

Efficacy and safety of progressively reducing biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in persistent remission: a study protocol for a non-inferiority randomized, controlled, single-blind trial
by: Shangwen Lei, et al.
Published: (2022-07-01)

Mangosteen ethanol extract alleviated the severity of collagen-induced arthritis in rats and produced synergistic effects with methotrexate
by: Jian Zuo, et al.
Published: (2018-01-01)

Late-onset rheumatoid arthritis has a similar time to remission as younger-onset rheumatoid arthritis: results from the Ontario Best Practices Research Initiative
by: Xiuying Li, et al.
Published: (2022-11-01)

Detection of Increased Relative Expression Units of <i>Bacteroides</i> and <i>Prevotella</i>, and Decreased <i>Clostridium leptum</i> in Stool Samples from Brazilian Rheumatoid Arthritis Patients: A Pilot Study
by: Guilherme S. P. Rodrigues, et al.
Published: (2019-10-01)

Effect of biological disease-modifying antirheumatic drugs on body composition in patients with rheumatoid arthritis: a systematic review and meta-analysis
by: Mariana Peixoto Guimarães Ubirajara e Silva de Souza, et al.
Published: (2022-05-01)

The Role of Vitamin D in Combination Treatment for Patients With Rheumatoid Arthritis
by: Jianhong Wu, et al.
Published: (2020-07-01)

CHANGES IN THE LEVEL OF FoxP3+ REGULATORY T LYMPHOCYTES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING METHOTREXATE THERAPY
by: A. S. Avdeeva, et al.
Published: (2017-09-01)

LONG-TERM SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OF MODERATE OR HIGH ACTIVITY (RESULTS OF PHASE III MULTICENTER EXTENSION CLINICAL STUDY ML28124)
by: E. L. Nasonov, et al.
Published: (2018-07-01)